MCM
GSK icon

Mason Capital Management’s GSK GSK Stock Holding History

Mason Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,720
Closed -$560K – 18
2021
Q3 		$560K Sell
11,720
-4,000
-25% -$201K 0.04% 29
2021
Q2 		$782K Buy
+15,720
New +$755K 0.05% 20

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Mason Capital Management's GSK Position: Q4 2021 in Review

Mason Capital Management sold out of GSK (GSK) in Q4 2021, closing a stake of 11,720 shares — an estimated $560K sold.

Mason Capital Management first reported a position in GSK in Q2 2021 and held it in 2 quarters. The position peaked at $782K in Q2 2021. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • Mason Capital Management reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
  • Mason Capital Management sold 11,720 GSK shares in Q4 2021, an estimated $560K.
  • Mason Capital Management first reported a position in GSK in Q2 2021 and held it in 2 quarters.
  • Mason Capital Management's GSK position peaked at $782K in Q2 2021.
  • 919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Mason Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.